Video

A ‘Lighthouse Through the Cancer Storm’

Author(s):

A nurse navigator explains how people in their profession create bonds with their patients and guide them through the cancer experience.

When asked what the oncology nurse navigator profession means to her, Tammy Allred, RN, OCN, said that it completed her. For patients, Allred said that nurse navigators represent, “the lighthouse in the storm.”

Allred, who is an oncology nurse navigator at University of North Carolina Lineberger Comprehensive Cancer Center, was a finalist for CURE®’s 2022 Extraordinary Healer®award, and in a recent interview, expressed how thankful she was to be able to bond with patients and help them through the cancer experience.

“You build a bond, and that bond continues through their treatment,” she said.

Transcription:

(Becoming a nurse navigator) completed me. I was able to do things, to be with people, to help people. It's not like if you were in the hospital working or in a clinic where the patients come in and then they leave. They come in, (and ) you're able to support them. You build a bond, and that bond continues on through their treatment. Whether they're in the hospital and home, it doesn't matter you're they are your that constant person.

One patient asked me what a navigator was. And I said, “I'm the lighthouse in your storm — the cancer is your storm. And I'm the lighthouse and I will guide you through this.”

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Image of Dr. Fakih.
.Dr. Catherine Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston
Image of Doctor with blonde hair.
Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based on patient feedback.
Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma who have diabetes.
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.
Dr. Neeraj Agarwal is a medical oncologist, a professor of medicine and the Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah, as well as director of the Genitourinary Oncology Program and the Center of Investigational Therapeutics at the Huntsman Cancer Institute in Salt Lake City.
Image of Dr. Goy.
Image of bald man.
Related Content